Showing results (791-800 of 816) with videos related to

Sort By:
Pageof 82
Bone Marrow Transplantation|December 18, 2007
Allogeneic hematopoietic cell transplantation for metastatic breast cancerN T Ueno, J D Rizzo, T Demirer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 27, 2015
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsA Abudayyeh, A Hamdi, H Lin, et al.
Leukemia & Lymphoma|March 8, 2000
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphomaM L Donato, R E Champlin, K W Van Besien, et al.
Journal of the National Cancer Institute|February 3, 2000
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaG N Hortobagyi, A U Buzdar, R L Theriault, et al.
Blood|November 24, 2001
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytesG E Georges, R Storb, B Bruno, et al.
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Blood|July 15, 1997
Bone marrow transplantation for severe aplastic anemia: has outcome improved?J R Passweg, G Socié, W Hinterberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Pageof 82